TipRanks
Shield Therapeutics PLC (DE:1JS)
FRANKFURT:1JS
Germany Market
1JS
Shield Therapeutics
RESEARCH TOOLSreports

Shield Therapeutics (1JS) Stock News & Sentiment

2 Followers
Shield Therapeutics updates total voting rights and share capital
Premium
Company Announcements
Shield Therapeutics updates total voting rights and share capital
1d ago
Shield Therapeutics Updates Total Voting Rights as Iron Drug Growth Continues
Premium
Company Announcements
Shield Therapeutics Updates Total Voting Rights as Iron Drug Growth Continues
1M ago
Shield Therapeutics Takes Full Control of U.S. ACCRUFeR Business to Boost Profitability
Premium
Company Announcements
Shield Therapeutics Takes Full Control of U.S. ACCRUFeR Business to Boost Profitability
1M ago
Shield Therapeutics narrows losses as ACCRUFeR® growth and global milestones lift H1 revenue
Premium
Company Announcements
Shield Therapeutics narrows losses as ACCRUFeR® growth and global milestones lift H1 revenue
1M ago
Shield Therapeutics updates total voting rights and underscores global iron therapy push
Premium
Company Announcements
Shield Therapeutics updates total voting rights and underscores global iron therapy push
2M ago
Shield Therapeutics grows H1 revenue, pivots commercial strategy and appoints new CFO
Premium
Company Announcements
Shield Therapeutics grows H1 revenue, pivots commercial strategy and appoints new CFO
2M ago
Shield’s pediatric trial backs ferric maltol in childhood iron deficiency anemia
Premium
Company Announcements
Shield’s pediatric trial backs ferric maltol in childhood iron deficiency anemia
2M ago
More DE:1JS News >

1JS News on the Web

Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
Proactive Investors
Bullish
Shield Therapeutics jumps 11% as losses narrow and profitability target held
Proactive Investors
Bullish
Shield Therapeutics issues shares under performance plan while keeping other incentive schemes unchanged
TipRanks News
Neutral
Shield Therapeutics Secures Strong Shareholder Backing at 2026 AGM
TipRanks News
Neutral
Shield Therapeutics updates share capital as iron deficiency franchise expands globally
TipRanks News
Neutral
Shield Therapeutics Hits Record ACCRUFeR Sales and Turns Cash-Flow Positive in 2025
TipRanks News
Neutral
Shield Therapeutics Gains Pediatric Boost as Ferric Maltol Data Published in Leading Journal
TipRanks News
Neutral
Shield Therapeutics updates share capital and underscores global iron deficiency franchise
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:1JS
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:1JS’s Media Buzz Sentiment?
1 articles about DE:1JS were published this week. In an average week, 0.5 articles are published.
    What is DE:1JS’s weekly average amount of articles?
    In an average week, 0.5 articles about DE:1JS are published.
      What is DE:1JS’s News Sentiment?
      50% of articles about DE:1JS were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week